Leibowitz Arthur S 4

What Happened Arthur S. Leibowitz, a director of Organogenesis Holdings, was granted 48,828 restricted stock units (RSUs) on February 18, 2026. The grant is reported at $0.00 per unit (no cash paid); each RSU represents the contingent right to one share of Organogenesis Class A common stock upon vesting. The RSUs vest in full on February 15, 2027.

Key Details

• Transaction date: 2026-02-18 (Form 4 filed 2026-02-20, appears timely).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 48,828 RSUs; grant price reported $0.00; reported value $0 at grant.
• Vesting: RSUs vest in full on February 15, 2027 (see footnote).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• No 10b5-1 plan, tax-withholding or cashless exercise noted in the provided footnotes.

Context RSUs are a common form of non-cash equity compensation for executives and directors; they convert into shares only after vesting and therefore do not represent immediate stock purchases or sales. Such awards are routine corporate compensation and do not by themselves indicate the insider is buying or selling stock for personal investment reasons.